BAD updates guideline on biologic therapy for psoriasis

The British Association of Dermatologists (BAD) has updated its guideline on biologic therapy for psoriasis. The guideline, which is accredited by NICE, provides evidence-based recommendations on the use of biologic therapies (including adalimumab, etanercept, infliximab, ixekizumab, secukinumab, and ustekinumab) in adults, children, and young people for the treatment of psoriasis. ...

Register or subscribe to view this content

Please sign in to continue reading this content, or …

Register for FREE

Guidelines for Nurses is free for UK-based doctors, nurses, and pharmacists.

Sign-up now—it takes just a few minutes and you’ll get unlimited access to all of our content, including summaries, expert articles, tools and resources, and CPD modules.

Or read for £5

Pay £5.00 to continue reading this content.

This will entitle you to unlimited access to our summaries, expert articles, and CPD modules for 30 days.